Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more
Health chiefs grant NHS emergency access to give severely ill Covid-19 patients promising Ebola drug remdesivir By Sam Blanchard Senior Health Reporter For Mailonline Published: 11:04 BST, 26 May 2020 | Updated: 11:07 BST, 26 May 2020 Coronavirus patients in Britain can now be treated with remdesivir, the Ebola drug which has shown promise in … Read more
Experts say even $10 is too much for the US-made antiviral drug approved to treat the novel coronavirus. Gilead Sciences’ medication, remdesivir, was shown to help reduce patients’ hospital stays over a placebo, in a clinical trial run by the National Institutes of Health. Last week, it became the first drug approved by the US … Read more
Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company. Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more
On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News. ‘Positive data’ from … Read more
Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings. ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more
The US Food and Drug Administration (FDA) may announce a decision today to allow emergency use of an antiviral drug to treat coronavirus patients. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leave hospital in two weeks. What’s more, Dr Anthony Fauci, the … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more
A trial of the antiviral drug remdesivir has produced ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday. Gilead announced the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus. Half of the 397 patients, who were sick enough … Read more
Doubts have been cast over the promising COVID-19 drug remdesivir that has shown ‘fantastic results’, after another study found it had no benefit. Remdesivir was reported by US officials to have ‘clear-cut’ evidence that it can help people recover from COVID-19, shortening the time of recovery. Dr Anthony Fauci, America’s top infectious disease expert, said … Read more